Health ❯ Clinical Research

Clinical Trials

Randomized Controlled Trials Phase 3 Trials Drug Efficacy Efficacy Studies Phase III Trials Patient Outcomes Dietary Interventions Vitamin D Studies Phase II Trials Data Analysis

Mexico Seeks Role as Latin America Clinical-Trial Hub With New Funding and AI

Coordinated regulatory reform, industry investment with AI aim to shorten approvals, boost capital and raise Mexico’s regional competitiveness

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

VDR Gene Variant Tied to 19% Lower Diabetes Risk With High-Dose Vitamin D3

Medicus Pharma Reports Long-Acting Hormone Control in Phase 1 Teverelix Data

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

Screening-Detected AF Carries Early, Threefold Heart Failure Risk in Swedish Trials

Boehringer Ingelheim Transfers CT-155 Commercial Rights to Click Therapeutics With $50 Million Backing

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

FDA Grants Accelerated Approval to Kresladi, First Gene Therapy for Severe Pediatric LAD-1

GLP-1 Drugs Tied to Lower Addiction Risk and Fewer Severe Outcomes in Major BMJ Analysis

Pilot Trial Signals Low-Dose Lithium May Slow Verbal Memory Decline in Mild Cognitive Impairment

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

Scientific Review Flags He Shou Wu as Multi-Pathway Candidate for Androgenetic Alopecia

EMA Panel Backs Conditional EU Approval for Rezurock in Chronic GvHD

NHS England to Offer Abiraterone to High-Risk Prostate Cancer Patients Within Weeks

Anvisa Approves Wegovy for MASH With Moderate-to-Advanced Fibrosis

MIT’s Light-Based Glucose Monitor Matches CGMs in Early Test as Wearable Trials Begin

Meta-Analysis Finds Nitrous Oxide Offers Rapid, Short-Lived Relief for Depression

Randomized Trial Finds Daily Coffee Lowers Atrial Fibrillation Recurrence After Cardioversion

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid